Americord Overview

  • Founded
  • 2008

Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Debt - PPP

  • Investors
  • 1

Americord General Information

Description

Operator of stem cell storage company intended to provide umbilical cord blood, cord tissue, and placental tissue stem cell banking. The company collects, processes, and stores newborn stem cells for future medical and therapeutic use, including the treatment of more than blood diseases such as sickle cell anemia and leukemia, enabling clinicians to develop a proprietary collection and extraction process of stem cells and people live longer and healthier lives.

Contact Information

Website
www.americordblood.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 225 Broadway
  • Suite 1903
  • New York, NY 10007
  • United States
+1 (866) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Americord Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 15-Apr-2020 00000 Completed Generating Revenue
1. Accelerator/Incubator 10-Jun-2014 00000 00000 Completed Generating Revenue
To view Americord’s complete valuation and funding history, request access »

Americord Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of stem cell storage company intended to provide umbilical cord blood, cord tissue, and placental tissue stem c
Other Healthcare Services
New York, NY
25 As of 2023
00000
000000000 - 00000

000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ve
00000 0000000000 000
Scottsdale, AZ
00 As of 0000
00000000000

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000 0000000000 000
Chennai, India
0000 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Americord Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AlphaCord Private Equity-Backed Scottsdale, AZ 00 00000000000
00000000 000000000 Venture Capital-Backed Chennai, India 0000 000.00 00000000000 000.00
0000-0000 00000000 Corporation Oldsmar, FL 00 00000 000000&0
00000 00000 000000 Corporate Backed or Acquired West Drayton, United Kingdom 00 000000&0
0000000 Corporate Backed or Acquired Waltham, MA 000000&0
You’re viewing 5 of 8 competitors. Get the full list »

Americord Patents

  • 7

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Americord Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11266696-B2 Method of treating stem cells with nad Active 18-Jan-2019 000000000 0
US-20200230175-A1 Method of preparing a stem cell source with reduced graft versus host disease risk and methods of using the same Active 18-Jan-2019 000000000
US-20200229426-A1 Isolation and cryopreservation of amniotic membrane sheets Active 18-Jan-2019 0000000000
US-11589574-B2 Compositions and methods for transport and preservation of biological material Active 18-Jan-2019 0000000000 0
US-20200229744-A1 Device for the improved collection of cord blood from an umbilical cord Pending 18-Jan-2019 A61B5/150038 00
To view Americord’s complete patent history, request access »

Americord Executive Team (5)

Name Title Board Seat Contact Info
Martin Smithmyer Founder, President & Co-Chief Executive Officer
Charlie Boyer Co-Chief Executive Officer & Chief Operating Officer
Robert Dracker Executive Medical Director
Christina Roccos Vice President, Medical Partnerships and Programs
You’re viewing 4 of 5 executive team members. Get the full list »

Americord Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Americord Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Start-up NY Accelerator/Incubator Minority 000 0000 000000 0
To view Americord’s complete investors history, request access »

Ready to get started?

Request a free trial